Huaxia Eye Hospital Group Co., Ltd. logo

Huaxia Eye Hospital Group Co., Ltd. (301267)

Market Open
11 Aug, 06:57
XSHE XSHE
¥
16. 84
+0.19
+1.1411%
¥
13.12B Market Cap
37.56 P/E Ratio
0.88% Div Yield
1.07M Volume
0 Eps
¥ 16.65
Previous Close
Add Transaction
Day Range
16.5 16.84
Year Range
14.46 22.95
Want to track 301267 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

301267 trading today higher at ¥16.84, an increase of 1.1411% from yesterday's close, completing a monthly increase of 16.0579% or ¥2.33. Over the past 12 months, 301267 stock lost -6.4444%.
301267 is not paying dividends to its shareholders.
The last earnings report, released on Oct 29, 2025, exceeded the consensus estimates by 0.1822%. On average, the company has surpassed earnings expectations by 0.1758%, based on the last three reports.
Huaxia Eye Hospital Group Co., Ltd. has completed 1 stock splits, with the recent split occurring on Jul 11, 2023.
The company's stock is traded on one exchange.

301267 Chart

People also search for

Aier Eye Hospital Group Co. Ltd.
¥ 9.05
-0.2205%
Haisco Pharmaceutical Group Co., Ltd.
¥ 70.17
-0.1565%
Shannon Semiconductor Tech Inc.
¥ 155.64
-0.6384%
Sichuan Kelun Pharmaceutical Co., Ltd.
¥ 47.33
+1.9823%
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
¥ 27.47
-0.5431%

Huaxia Eye Hospital Group Co., Ltd. (301267) FAQ

What is the stock price today?

The current price is ¥16.84.

On which exchange is it traded?

Huaxia Eye Hospital Group Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 301267.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.88%.

What is its market cap?

As of today, the market cap is 13.12B.

Has Huaxia Eye Hospital Group Co., Ltd. ever had a stock split?

Huaxia Eye Hospital Group Co., Ltd. had 1 splits and the recent split was on Jul 11, 2023.

Huaxia Eye Hospital Group Co., Ltd. Profile

Health Care Providers & Services Industry
Healthcare Sector
Mr. Qingcan Su CEO
XSHE Exchange
CNE100005WL5 ISIN
CN Country
8,200 Employees
- Last Dividend
11 Jul 2023 Last Split
- IPO Date

Overview

Huaxia Eye Hospital Group Co.,Ltd. is a leading entity in the ophthalmic medical field both within China and internationally. Founded in 1997 and headquartered in Xiamen, China, the hospital group specializes in offering a comprehensive range of ophthalmic services. Its commitment to pioneering eye care has established it as a prominent name in ophthalmology. By providing expert diagnosis and treatment across a variety of eye-related ailments, Huaxia Eye Hospital Group has carved out a significant niche in the healthcare sector. Catering to patients with varying ophthalmic diseases, the group leverages advanced technology and in-depth expertise to ensure optimal care and treatment outcomes.

Products and Services

  • Refractive Surgery

    This service addresses vision correction needs, utilizing state-of-the-art laser technologies to correct refractive errors such as myopia, hyperopia, and astigmatism, thereby reducing or eliminating the need for eyeglasses or contact lenses.

  • Optometry

    Huaxia Eye Hospital Group offers comprehensive eye exams and vision care, including the prescription of eyeglasses and contact lenses, alongside assessments for eye health to detect and manage ocular diseases.

  • Pediatric Strabismus

    Specializing in the diagnosis and treatment of strabismus (misalignment of the eyes) in children, this service aims to improve vision, eye coordination, and the appearance of the eyes through various therapeutic approaches.

  • Cataract

    The cataract service focuses on the removal of cloudy areas in the lens of the eye, which can lead to decreased vision. Advanced surgical procedures are employed to restore clarity and improve the quality of life for patients.

  • Fundus Disease

    Specifically targeting the treatment of diseases affecting the fundus of the eye, such as diabetic retinopathy and age-related macular degeneration, this service utilizes leading diagnostic and treatment methods to preserve and enhance vision.

  • Ocular Surface and Corneal Disease

    This service is dedicated to diagnosing and treating conditions affecting the cornea and the surface of the eye, including dry eye syndrome, keratitis, and other corneal dystrophies, with the aim of restoring eye health and comfort.

  • Glaucoma

    Offering advanced diagnostic and treatment options for glaucoma, this service focuses on managing the condition to prevent further loss of vision by controlling intraocular pressure, utilizing medication, laser treatment, or surgery as needed.

  • Eye Trauma

    Providing immediate and effective treatment for eye injuries, this service ensures the best possible recovery outcomes for patients experiencing various forms of eye trauma, utilizing the latest in surgical and non-surgical treatment methods.

  • Eye Plastic Surgery

    Encompassing both cosmetic and reconstructive procedures, the eye plastic surgery services offered deal with the aesthetic improvement as well as functional repair of the eye and its surrounding structures, addressing conditions such as eyelid malformations or injuries.

Contact Information

Address: No. 999 Wutong West Road, Xiamen, China, 361006
Phone: 86 40 0611 2222